These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38006448)

  • 1. Progress of nanomaterials in the treatment of thrombus.
    Shen Y; Yu Y; Zhang X; Hu B; Wang N
    Drug Deliv Transl Res; 2024 May; 14(5):1154-1172. PubMed ID: 38006448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery.
    Ren T; Mi Y; Wei J; Han X; Zhang X; Zhu Q; Yue T; Gao W; Niu X; Han C; Wei B
    Molecules; 2024 May; 29(10):. PubMed ID: 38792186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances of nanomedicine in treatment of atherosclerosis and thrombosis.
    Mao Y; Ren J; Yang L
    Environ Res; 2023 Dec; 238(Pt 2):116637. PubMed ID: 37482129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional gold nanoparticles for diagnosis, treatment and prevention of thrombus.
    Lv J; Zhang L; Du W; Ling G; Zhang P
    J Control Release; 2022 May; 345():572-585. PubMed ID: 35346766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of nanotechnology in thrombus therapy.
    Liao K; Wu Q; Li Y; Wu C; Zhou Y; Zeng Q
    J Mater Chem B; 2023 Jun; 11(23):5043-5050. PubMed ID: 37211877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine progress in thrombolytic therapy.
    Zenych A; Fournier L; Chauvierre C
    Biomaterials; 2020 Nov; 258():120297. PubMed ID: 32818824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.
    Pawlowski CL; Li W; Sun M; Ravichandran K; Hickman D; Kos C; Kaur G; Sen Gupta A
    Biomaterials; 2017 Jun; 128():94-108. PubMed ID: 28314136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
    Ma H; Jiang Z; Xu J; Liu J; Guo ZN
    Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy.
    Wang S; Wang R; Meng N; Guo H; Wu S; Wang X; Li J; Wang H; Jiang K; Xie C; Liu Y; Wang H; Lu W
    J Control Release; 2020 Dec; 328():78-86. PubMed ID: 32853731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elaborately Engineering a Self-Indicating Dual-Drug Nanoassembly for Site-Specific Photothermal-Potentiated Thrombus Penetration and Thrombolysis.
    Zhao Z; Zhang X; Zhang H; Shan X; Bai M; Wang Z; Yang F; Zhang H; Kan Q; Sun B; Sun J; He Z; Luo C
    Adv Sci (Weinh); 2022 Feb; 9(4):e2104264. PubMed ID: 34802198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-inspired nanomaterials as novel options for the treatment of cardiovascular disease.
    Bose RJ; Ha K; McCarthy JR
    Drug Discov Today; 2021 May; 26(5):1200-1211. PubMed ID: 33561512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-circulating nanoparticles as passive targeting nanocarriers for the treatment of thrombosis.
    Li J; Lu K; Sun S; Peng J; Zhao L
    Nanoscale; 2024 Mar; 16(12):6132-6141. PubMed ID: 38444355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy.
    McCarthy JR; Sazonova IY; Erdem SS; Hara T; Thompson BD; Patel P; Botnaru I; Lin CP; Reed GL; Weissleder R; Jaffer FA
    Nanomedicine (Lond); 2012 Jul; 7(7):1017-28. PubMed ID: 22348271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging nanotherapeutics for antithrombotic treatment.
    Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C
    Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Nanotechnology in Thrombus Therapy.
    Zhou S; Zhao W; Hu J; Mao C; Zhou M
    Adv Healthc Mater; 2023 Mar; 12(7):e2202578. PubMed ID: 36507827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic Nanoplatelets to Target Delivery Hirudin for Site-Specific Photothermal/Photodynamic Thrombolysis and Preventing Venous Thrombus Formation.
    Li S; Zhang K; Ma Z; Zhang W; Song Z; Wang W; Han H
    Small; 2022 Dec; 18(51):e2203184. PubMed ID: 36344452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy.
    Zhao Z; Li X; Wang Y; Liu C; Ling G; Zhang P
    J Nanobiotechnology; 2023 Nov; 21(1):439. PubMed ID: 37990207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.